Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Fucosterol.
Fucosterol is a marine-derived phytosterol that exerts neuroprotective, anti-diabetic, and anti-inflammatory effects primarily through the modulation of the PI3K/Akt and MAPK signaling pathways.
5281328
412.7 g/mol
8.9
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(E,2R)-5-propan-2-ylhept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Fucosterol across standard consumer modalities.
The high lipophilicity of fucosterol necessitates the use of oil-based carriers or surfactants to prevent poor dissolution and erratic bioavailability in dry powder formats.
Incorporating fucosterol into pectin-based matrices requires careful emulsification to prevent phase separation and a gritty texture due to its crystalline nature.
The low aqueous solubility and relatively high dosage requirements of fucosterol pose significant challenges for achieving a uniform payload within the limited thickness of thin-film polymers.
Ready to launch a product featuring Fucosterol? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Fucosterol extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Fucosterol payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation